Liver Preservation Systems Market was valued at USD 174.2 million in 2021. It is expected to reach a value of USD 1,949.5 million by 2028, growing at a CAGR of 41.2% from 2022-2028. Liver Preservation Systems is defined as the kind of technique that is used for recognizing numerous preservation solutions found in poultry. The method includes chickens, ducks, waterfowl, turkeys, and other birds. Several preservation solutions are seen in birds, such as Avian Mycoplasmosis, Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, and others. A liver transplant, also called a hepatic transplant, can assist to save a person’s life when the liver no longer functions. A doctor may counsel a liver transplant for an individual with end-stage liver illness. The rising prevalence of liver diseases and rising liver transplants as well as numerous products launched by the global market players. Liver preservation is the procedure of maintaining and protecting the donor liver from the liver gaining up to the establishment in the anticipated recipients. Oxygenation, Temperature, and other appropriate storage condition are to be kept to avoid liver injury throughout the preservation time, and liver works after the transplantation to recipients. The liver can be preserved in the preservation solution which is temperature-cooled to slow down the procedure of liver worsening from normal metabolic procedure. Liver procurement is typically achieved after the cardiac biomarkers death or brain death of the patients. The global market provides a detailed overview of the and that can be segmented by preservation technique, by preservation solution, and by End user. By preservation technique, the Liver Preservation Systems market growth has been segmented into Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS), Others. The Static Cold Storage (SCS) segment is likely to be the significant growing segment in terms of preservation technique. Based on Preservation solution, the Liver Preservation Systems market is segmented into Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution, Human Biosystem (HBS) Solution, Renograf, Viaspen, Lifor, Perfadex, and Others. Among these, the Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution preservation solution segment is expected to have the significant growing market during the forecast period 2022-2028. Based on the End user, the Liver Preservation Systems market is segmented into Hospitals, Clinics, Others. Key Development: In November 2021, Paragonix Technologies introduced the LIVERguard Donor Liver Preservation System in Europe and United States In September 2021, TransMedics Group, Inc. announced the premarketing approval by the U.S FDA of its OCS Liver System for usage with organs from donors who expired after circulatory death (DCD) or after brain death (DBD).